BJT-778

· Mirum Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BJT-778, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection [Phase 2, Phase 3]

See pricing